Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -96.56% is 86% above its 5-year average of -675.76%, near the high end of its 5-year range (-50346.15%–8.92%).
73.79% above its 12-month average of -368.41%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1113.30%.
OPERATING MARGIN
-96.56%
OPERATING MARGIN AVG TTM
-368.41%
OPERATING MARGIN AVG 3Y
-510.62%
OPERATING MARGIN AVG 5Y
-675.76%
OPERATING MARGIN AVG 10Y
-839.05%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+73.79%
CURRENT VS 3Y AVG
+81.09%
CURRENT VS 5Y AVG
+85.71%
CURRENT VS 10Y AVG
+88.49%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cue Biopharma, Inc.
Market Cap
$176.96M
Operating Margin
-96.56%
TTM Avg
-368.41%
3Y Avg
-510.62%
5Y Avg
-675.76%
Market Cap
$179.70M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$174.17M
Operating Margin
-152.19%
TTM Avg
-95.13%
3Y Avg
-132.07%
5Y Avg
-169.10%
Market Cap
$173.04M
Operating Margin
-425.72%
TTM Avg
-233.78%
3Y Avg
-167.06%
5Y Avg
-119.37%
Market Cap
$172.99M
Operating Margin
0.00%
TTM Avg
-3330.88%
3Y Avg
-1665.44%
5Y Avg
-1110.29%
Market Cap
$184.12M
Operating Margin
-13.21%
TTM Avg
-18.79%
3Y Avg
-19.38%
5Y Avg
-19.19%
Market Cap
$162.82M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-615.66%
Market Cap
$192.97M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$160.82M
Operating Margin
-8.45%
TTM Avg
-10.66%
3Y Avg
-19.64%
5Y Avg
-13.31%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | $176.96M | -96.56% | -368.41% | -510.62% | -675.76% |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | -152.19% | -95.13% | -132.07% | -169.10% |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | -425.72% | -233.78% | -167.06% | -119.37% |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | 0.00% | -3330.88% | -1665.44% | -1110.29% |
| Journey Medical Corporation (DERM)vs › | $184.12M | -13.21% | -18.79% | -19.38% | -19.19% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | 0.00% | 0.00% | 0.00% | -615.66% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | 0.00% | 0.00% | 0.00% | 0.00% |
| Inogen, Inc. (INGN)vs › | $160.82M | -8.45% | -10.66% | -19.64% | -13.31% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | 0.00% | 0.00% | 0.00% | -91.83% |
Gross Margin
99.7%
Operating Margin
-96.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1113.30% |
| 2026-03-31 | -94.32% |
| 2025-12-31 | 8.92% |
| 2025-09-30 | -351.05% |
| 2025-06-30 | -292.32% |
| 2025-03-31 | -2921.38% |
| 2024-12-31 | -611.23% |
| 2024-09-30 | -264.24% |
| 2024-06-30 | -390.63% |
| 2024-03-31 | -737.80% |
| 2023-12-31 | -759.58% |
| 2023-09-30 | -543.76% |
| 2023-06-30 | -978.08% |
| 2023-03-31 | -7155.08% |
| 2022-12-31 | -9845.03% |
| 2022-09-30 | -16222.06% |
| 2022-06-30 | -50346.15% |
| 2022-03-31 | -1423.80% |
| 2021-12-31 | -95.62% |
| 2021-09-30 | -543.55% |
| 2021-06-30 | -376.16% |
| 2021-03-31 | -806.05% |
| 2020-12-31 | -2308.86% |
| 2020-09-30 | -1439.06% |
| 2020-06-30 | -1017.86% |
| 2020-03-31 | -1443.89% |
| 2019-12-31 | -859.14% |
| 2019-09-30 | -720.93% |
| 2019-06-30 | -874.98% |
| 2019-03-31 | -3088.38% |
| 2018-12-31 | -3317.16% |
| 2018-09-30 | -2841.65% |
| 2018-06-30 | -4344.19% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
